other

Updated:

Global Market Enterprise Ltd

Global Market Enterprise Ltd was founded in 2006 to develop and commercialize sustainable nanotechnology. It maintains dual headquarters in Chicago and Dubai,...

Global Market Enterprise Ltd

Global Market Enterprise Ltd was founded in 2006 to develop and commercialize sustainable nanotechnology. It maintains dual headquarters in Chicago and Dubai, sells nano-based water treatment products, agricultural inputs, and healthcare materials through distribution partners in 33 countries, and has tested its products on 48 crop types while conducting water-quality projects to control algal blooms. The firm has sponsored over 255 free trials and donated products for humanitarian projects; it runs a single operating entity that develops, commercializes, and markets its own nanotechnology and has disclosed neither team size, total deployment, nor any fund structures or external commitments.

General information

Firm type

other

Year founded

2006

Location

Region

North America

Country

United States

City

Chicago

Corporate office

Chicago, Dubai, United States

Additional offices

Dubai

Sector focus

ClimateTechAgriTech & FoodTechIndustrial Tech

Frequently asked questions

Who runs investment decisions at Global Market Enterprise Ltd?

The firm does not publicly name any principals, investment committee, or decision-makers. Its website lists no individual executives or directors, so the governance structure is not transparent.

How does Global Market Enterprise source proprietary deal flow?

The firm develops and markets its own patented nanotechnology internally, rather than sourcing external deals or investments. It functions as an operating company that commercializes its own technologies, which means deal flow is limited to its own R&D pipeline (per the firm's website).

What sectors does Global Market Enterprise focus on?

The firm targets three primary sectors: environmental protection (water treatment), sustainable agriculture (crop protection, fertilizers), and global healthcare. It does not avoid any specific sectors in its public materials, but its entire portfolio is built around green nanotechnology.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Chicago other profiles